Skip to main content
Fig. 2 | Biomarker Research

Fig. 2

From: Potential non-invasive biomarkers in tumor immune checkpoint inhibitor therapy: response and prognosis prediction

Fig. 2

Visualization of tumor and TME with radiotracers and PET imaging in vivo. PET, Positron emission tomography; GZMB, Granzyme B; IFN-γ, Interferon-gamma; MHC, Major histocompatibility complex; PD-L1, Programmed cell death-ligand 1; PD-1, Programmed cell death-1; APC, Antigen presenting cell; LAG, Lymphocyte-activation gene; TCR, T cell receptor; TME, Tumor microenvironment; 89Zr, Zirconium-89; 68 Ga, Gallium-68

Back to article page